Primary myelofibrosis: treatments, associated drugs and conditions
Primary myelofibrosis: primary disorder of the bone marrow.
We study 35,056 people who have Primary myelofibrosis. The information that eHealthMe analyzes includes:- COVID vaccines that are associated with Primary myelofibrosis
- Medications that treat Primary myelofibrosis and their effectiveness
- 1,090 drugs that are associated with Primary myelofibrosis
- 769 conditions that are associated with Primary myelofibrosis
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
Number of reports submitted per year:
COVID vaccines that are associated with Primary myelofibrosis:
- Primary myelofibrosis in Moderna COVID Vaccine
- Primary myelofibrosis in Pfizer BioNTech Covid Vaccine
- Primary myelofibrosis in Johnson and Johnson Covid Vaccine
Primary myelofibrosis treatments and how effective are they?
Common drugs associated with Primary myelofibrosis:
- Jakafi: 776 reports
- Aspirin: 275 reports
- Hydrea: 264 reports
- Lopurin: 171 reports
- Allopurinol: 171 reports
- Exjade: 156 reports
- Nplate: 155 reports
- Prednisone: 152 reports
- Hydroxyurea: 141 reports
- Prednisolone: 141 reports
All the drugs that are associated with Primary myelofibrosis:
- Primary myelofibrosis (1,090 drugs)
Common conditions associated with Primary myelofibrosis:
- High blood pressure: 141 reports
- Idiopathic thrombocytopenic purpura (itp): 108 reports
All the conditions that are associated with Primary myelofibrosis:
- Primary myelofibrosis (769 conditions)
Browse all Primary myelofibrosis symptoms:a b c d e f g h i j k l m n o p q r s t u v w x y z
Do you take any medication?- You can start a phase IV clinical trial to monitor drug safety and effectiveness.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.
Recent studies on eHealthMe:
- Cytotec and Fatty Liver - now
- Depakote and Fracture Displacement - 3 seconds ago
- Danocrine and Hypertension Aggravated - 8 seconds ago
- Darvon-N and Monoplegia - 10 seconds ago
- Cytoxan and Metastases To Liver - 10 seconds ago
- Ranitidine and Hyperkalemia - 14 seconds ago
- Dapsone and Vitreous Floaters - 15 seconds ago
- Cytoxan and Meningitis - 22 seconds ago
- Lantus Solostar and Facial Pain - 25 seconds ago
- Zepatier and Fibromyalgia - 30 seconds ago